<DOC>
	<DOC>NCT02106962</DOC>
	<brief_summary>This study will investigate how the use of Tranexamic acid and Bacitracin applied to the bleeding site after the hemodialysis fistula needle is removed will affect skin wound healing.</brief_summary>
	<brief_title>Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients</brief_title>
	<detailed_description />
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Arteriovenous Fistula</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<mesh_term>Bacitracin</mesh_term>
	<criteria>Dialysis patients with fistulas (native arteriovenous) Previous sensitivity to or adverse reaction to Tranexamic acid or Bacitracin. Active infection. Stenosis of fistula.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>hemodialysis</keyword>
	<keyword>fistula</keyword>
	<keyword>clotting</keyword>
	<keyword>tranexamic acid</keyword>
	<keyword>bacitracin</keyword>
</DOC>